Study for infections from antibiotic-resistant bacteria
Part of Digestive system, Genetic & congenital, Infections, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (the study is for adults only)
- You have a confirmed infection in one of these areas: urine, lungs (pneumonia), or a deeper infection
- The germ found in the lab must be one of these: E. coli, Klebsiella, Staphylococcus aureus (S. aureus), or Pseudomonas aeruginosa (P. aeruginosa)
- If you are in a control group, your routine lab test must show no bacteria and you must have no other infection for 10 days
- You must agree to participate with general research consent (you can’t refuse or block reuse of samples/data)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well two strong antibiotics (ceftazidime/avibactam and cefiderocol) work, with or without another drug called fosfomycin, for treating tough Gram-negative infections. It aims to help doctors understand the best way to use these medicines.
This trial looks at how well two antibiotics, ceftazidime-avibactam and fosfomycin, work together to treat infections caused by highly resistant bacteria called CRE. It may help find the best way to use these medicines.
This study looks at why some healthy people carry resistant bacteria in their gut (called ESBL-producing bacteria). Researchers will collect stool and urine samples and ask about your daily life to find possible risk factors. You won't receive any treatment, but your participation can help scientists understand how to prevent the spread of these bacteria.
This study looks at urine infections caused by certain resistant bacteria. If you had a UTI treated by your family doctor between June and December 2024, your doctor may help us learn more about these infections and how to treat them better.
This study builds a Swiss database using lab genetic testing (whole genome sequencing) plus basic patient information to track outbreaks of serious, drug-resistant, and sometimes high-infectious pathogens. Your data could help researchers understand how these germs spread and how to better prevent them.
This study looks at how bacteria in the lungs become resistant to antibiotics in people with chronic lung disease. It aims to understand this process to improve treatment and prevent infections.
Hear when a new Antimicrobial Resistance (AMR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.